מאקליבן 400 מג 5 מל

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

AMOXICILLIN AS TRIHYDRATE; CLAVULANIC ACID AS POTASSIUM

Disponible depuis:

NOVARTIS ISRAEL LTD

Code ATC:

J01CA04

forme pharmaceutique:

אבקה להכנת תרחיף

Composition:

AMOXICILLIN AS TRIHYDRATE 400 MG / 5 ML; CLAVULANIC ACID AS POTASSIUM 57 MG / 5 ML

Mode d'administration:

פומי

Type d'ordonnance:

מרשם נדרש

Fabriqué par:

SANDOZ GmbH, AUSTRIA

Groupe thérapeutique:

AMOXICILLIN

Domaine thérapeutique:

AMOXICILLIN

indications thérapeutiques:

For the treatment of lower respiratory tract infections, otitis media infections, sinusitis infections, acute pharyngitis, skin and soft tissues infections and urinary tract infections caused by beta-lactamase producing organisms which are susceptible to Amoxycillin + Potassium clavulanate and are resistant to other beta-lactam antibiotics.

Date de l'autorisation:

2015-03-31